{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:58:28Z","timestamp":1785481108307,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To share real-world experiences and insights regarding complications associated with intrathecal baclofen (ITB) therapy from a major Chinese tertiary center, providing practical guidance for regions where ITB use is still emerging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-center, single-surgeon retrospective analysis was conducted on all patients who received ITB pump implantation at Ruijin Hospital (Shanghai, China) between 1st Jan 2011, and 31st Oct 2025. Data on demographics, medical history, and ITB-associated complications were extracted. Clinical effectiveness was assessed using a 5-level Likert scale of goal achievement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 68 individuals (44 males), representing 214.3 pump-years of therapy, were included. The most common supra-spinal pathology was cerebral palsy (10\/68, 14.7%), and the predominant spinal pathology was traumatic spinal cord injury (23\/68, 33.8%). 87.2% of individuals reported to have goals considered achieved or partially achieved. A total of 24 complications were documented in 19 individuals. The overall complication incidence was 0.11 events per pump-year and 0.30 per implantation. Catheter-related issues were the most frequent (8\/24, 33.3%), followed by drug-related (7\/24, 29.2%) and procedure-related (6\/24, 25.0%) complications. Human error-related issues accounted for 25.0% (6\/24) of all documented complications. Notably, refinement of surgical nuances was found to successfully mitigate wound tension and skin erosion. In addition, a multimodal neuromodulation strategy integrating sacral neuromodulation was successfully piloted in a representative case of ITB dose-limiting urinary retention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study presents\u00a0one of the largest reported ITB cohort in China. Our experiences underscore that long-term success in ITB therapy extends beyond surgical precision to encompass systemic clinical governance, including rigorous safety protocols and the management of refractory side effects through multimodal neuromodulation approaches. These insights, including the novel use of multimodal neuromodulation to manage dose-limiting adverse effects of ITB, may help optimize ITB practice, particularly in regions where its use is still emerging.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00701-026-06936-x","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:57:05Z","timestamp":1780577825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fifteen years of intrathecal baclofen therapy in China: complications, safety governance, and a multimodal neuromodulation strategy"],"prefix":"10.1007","volume":"168","author":[{"given":"Zhengyu","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"6936_CR1","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.2147\/jpr.S520502","volume":"18","author":"DW Banks","year":"2025","unstructured":"Banks DW, Jevotovsky DS, Oehlermarx W, Broachwala M, Gulati A, Chakravarthy K (2025) Pocket fills for intrathecal pump delivery systems: a narrative review. J Pain Res 18:3519\u20133526. https:\/\/doi.org\/10.2147\/jpr.S520502","journal-title":"J Pain Res"},{"key":"6936_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejpn.2022.02.002","volume":"37","author":"LA Bonouvri\u00e9","year":"2022","unstructured":"Bonouvri\u00e9 LA, Lagendijk KE, Beckerman H, Slot KM, van de Pol LA, Buizer AI (2022) Surgical complications of intrathecal baclofen in children: a single centre, 20-year retrospective cohort study. Eur J Paediatr Neurol 37:94\u201397. https:\/\/doi.org\/10.1016\/j.ejpn.2022.02.002","journal-title":"Eur J Paediatr Neurol"},{"key":"6936_CR3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/STROKEAHA.118.022255","volume":"49","author":"M Creamer","year":"2018","unstructured":"Creamer M, Cloud G, Kossmehl P, Yochelson M, Francisco GE, Ward AB, Wissel J, Zampolini M, Abouihia A, Calabrese A, Saltuari L, Van der Looven R, Bouche K, Rubin B, Khurana S, Moraleda S, Bender A, Ruijgrok J, Shilt J, Lejeune T, Ebke M, Molteni F, Lawson M, Grabljevec K, Dalton C, Matzak H (2018) Effect of intrathecal baclofen on pain and quality of life in poststroke spasticity. Stroke 49:2129\u20132137. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022255","journal-title":"Stroke"},{"key":"6936_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bjae.2019.11.002","volume":"20","author":"EM Delhaas","year":"2020","unstructured":"Delhaas EM, Huygen F (2020) Complications associated with intrathecal drug delivery systems. BJA Educ 20:51\u201357. https:\/\/doi.org\/10.1016\/j.bjae.2019.11.002","journal-title":"BJA Educ"},{"key":"6936_CR5","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/ner.13412","volume":"24","author":"CN Feller","year":"2021","unstructured":"Feller CN, Awad AJ, Nelson MES, Ketchum N, Pahapill PA (2021) Low rate of intrathecal baclofen pump catheter-related complications: long-term study in over 100 adult patients associated with reinforced catheter. Neuromodulation 24:1176\u20131180. https:\/\/doi.org\/10.1111\/ner.13412","journal-title":"Neuromodulation"},{"key":"6936_CR6","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.pmrj.2009.07.015","volume":"1","author":"GE Francisco","year":"2009","unstructured":"Francisco GE, Saulino MF, Yablon SA, Turner M (2009) Intrathecal baclofen therapy: an update. PM R 1:852\u2013858. https:\/\/doi.org\/10.1016\/j.pmrj.2009.07.015","journal-title":"PM R"},{"key":"6936_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2024.101919","volume":"68","author":"M Gahier","year":"2025","unstructured":"Gahier M, Hirardot T, Buffenoir K, Perrouin-Verbe B, Gross R (2025) Complications of intrathecal baclofen therapy for spasticity: a single-centre cohort of 170 individuals. Ann Phys Rehabil Med 68:101919. https:\/\/doi.org\/10.1016\/j.rehab.2024.101919","journal-title":"Ann Phys Rehabil Med"},{"key":"6936_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.53425","volume":"16","author":"E Guzman","year":"2024","unstructured":"Guzman E, Barbari C, Paganoni J, Cohen J, Delgado-Lebron J (2024) Position-dependent intrathecal baclofen system catheter failure resulting in debilitating spasticity: a case report. Cureus 16:e53425. https:\/\/doi.org\/10.7759\/cureus.53425","journal-title":"Cureus"},{"issue":"10","key":"6936_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sc.2009.34","volume":"47","author":"HW Heetla","year":"2009","unstructured":"Heetla HW, Staal MJ, Kliphuis C, van Laar T (2009) The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord 47(10):751\u2013756. https:\/\/doi.org\/10.1038\/sc.2009.34","journal-title":"Spinal Cord"},{"key":"6936_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70720","volume":"16","author":"JW Leiphart","year":"2024","unstructured":"Leiphart JW, Leiphart TJ (2024) Scar tissue catheter tip occlusion from an intrathecal baclofen delivery: a case report and review of the literature. Cureus 16:e70720. https:\/\/doi.org\/10.7759\/cureus.70720","journal-title":"Cureus"},{"key":"6936_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00701-024-06315-4","volume":"166","author":"Z Lin","year":"2024","unstructured":"Lin Z, Huang P, Pan Y, Shen R, Lin S, Wu Y, Li D (2024) Intraventricular baclofen for intractable spasticity and secondary dystonia: a frame-based stereotactic approach and case series. Acta Neurochir (Wien) 166:420. https:\/\/doi.org\/10.1007\/s00701-024-06315-4","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"6936_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6904-4-6","volume":"4","author":"I Mohammed","year":"2004","unstructured":"Mohammed I, Hussain A (2004) Intrathecal baclofen withdrawal syndrome- a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 4(1):6. https:\/\/doi.org\/10.1186\/1472-6904-4-6","journal-title":"BMC Clin Pharmacol"},{"key":"6936_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.nrleng.2025.06.011","volume":"40","author":"I Otero-Luis","year":"2025","unstructured":"Otero-Luis I, Saz-Lara A, Cavero-Redondo I, Pascual-Morena C, Mart\u00ednez-Garc\u00eda I, Nu\u00f1ez de Arenas-Arroyo S (2025) Effectiveness of the intrathecal baclofen pump in the treatment of spasticity of different aetiologies: a systematic review and meta-analysis. Neurolog\u00eda (English Edition) 40:577\u2013585. https:\/\/doi.org\/10.1016\/j.nrleng.2025.06.011","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"5","key":"6936_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.965","volume":"8","author":"E Pucks-Faes","year":"2018","unstructured":"Pucks-Faes E, Hitzenberger G, Matzak H, Fava E, Verrienti G, Laimer I, Fritz J, Saltuari L (2018) Eleven years\u2019 experience with intrathecal baclofen - complications, risk factors. Brain Behav 8(5):e00965. https:\/\/doi.org\/10.1002\/brb3.965","journal-title":"Brain Behav"},{"key":"6936_CR15","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/s0022-5347(05)64292-9","volume":"168","author":"WA Scheepens","year":"2002","unstructured":"Scheepens WA, de Bie RA, Weil EH, van Kerrebroeck PE (2002) Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J Urol 168:2046\u20132050. https:\/\/doi.org\/10.1016\/s0022-5347(05)64292-9","journal-title":"J Urol"},{"key":"6936_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/1545968310363585","volume":"24","author":"I Stetkarova","year":"2010","unstructured":"Stetkarova I, Yablon SA, Kofler M, Stokic DS (2010) Procedure- and device-related complications of intrathecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair 24:609\u2013619. https:\/\/doi.org\/10.1177\/1545968310363585","journal-title":"Neurorehabil Neural Repair"},{"key":"6936_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/wco.0000000000001114","volume":"35","author":"S Tamburin","year":"2022","unstructured":"Tamburin S, Filippetti M, Mantovani E, Smania N, Picelli A (2022) Spasticity following brain and spinal cord injury: assessment and treatment. Curr Opin Neurol 35:728\u2013740. https:\/\/doi.org\/10.1097\/wco.0000000000001114","journal-title":"Curr Opin Neurol"},{"key":"6936_CR18","doi-asserted-by":"publisher","DOI":"10.3171\/2024.3.Focus2471","volume":"56","author":"J Tiefenbach","year":"2024","unstructured":"Tiefenbach J, Machado AG, Bethoux F (2024) Uncovering the rate and risk factors of intrathecal baclofen pump-associated complications in the adult population. Neurosurg Focus 56:E12. https:\/\/doi.org\/10.3171\/2024.3.Focus2471","journal-title":"Neurosurg Focus"},{"key":"6936_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00192-010-1276-0","volume":"21","author":"PEV Van Kerrebroeck","year":"2010","unstructured":"Van Kerrebroeck PEV (2010) Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms. Int Urogynecol J 21:467\u2013474. https:\/\/doi.org\/10.1007\/s00192-010-1276-0","journal-title":"Int Urogynecol J"},{"key":"6936_CR20","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s12325-021-01650-9","volume":"38","author":"A van Ophoven","year":"2021","unstructured":"van Ophoven A, Engelberg S, Lilley H, Sievert KD (2021) Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (nLUTD): over 20 years\u2019 experience and future directions. Adv Ther 38:1987\u20132006. https:\/\/doi.org\/10.1007\/s12325-021-01650-9","journal-title":"Adv Ther"},{"key":"6936_CR21","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00006123-200003000-00017","volume":"46","author":"P Van Schaeybroeck","year":"2000","unstructured":"Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P (2000) Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 46:603\u2013609. https:\/\/doi.org\/10.1097\/00006123-200003000-00017","journal-title":"Neurosurgery"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-026-06936-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-026-06936-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-026-06936-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:08:00Z","timestamp":1785478080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-026-06936-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6936"],"URL":"https:\/\/doi.org\/10.1007\/s00701-026-06936-x","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Given the retrospective nature of the study, the Ethics Committee of Ruijin Hospital (Shanghai, China) reviewed the study protocol and confirmed that formal ethical approval was not required. All participants have given written informed consent for surgery and the subsequent follow-ups. All participants provided written informed consent for both the surgical procedures and subsequent follow-up assessments. Additionally, the authors affirm that specific informed consent was obtained from the participants for the publication of images in Figs.\u00a0\n                      \n                      ,\n                      \n                      , and\n                      \n                      . (Clinical trial number: not applicable).","order":1,"name":"Ethics","label":"Ethics approval and consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}